Author:
Chatelut E.,Pivot X.,Otto J.,Chevreau C.,Thyss A.,Renée N.,Milano G.,Canal P.
Reference21 articles.
1. Pharmacokinetics and dosage reduction of cis-diammine (1,1-cyclobutanedicarboxylato) platinum in patients with impaired renal function;Egorin;Cancer Res.,1984
2. Prospective validation of a pharmacokinetically based dosing schema for the cis-diamminedichloroplatinum (II) analogue diamminecyclobutane-dicarboxylato-platinum;Egorin;Cancer Res.,1985
3. Carboplatin dosage;Calvert;J. Clin. Oncol.,1989
4. Prediction of carboplatin clearance from standard morphological and biological patient characteristics;Chatelut;J. Natl. Cancer Inst.,1995
5. Effectiveness of carboplatin, etoposide and bleomycin combination chemotherapy in good-prognosis metastatic germ cell tumors;Horwich;J. Clin. Oncol.,1991
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献